Profil
Michael Stowell is the founder of AmideBio LLC, where he currently holds the title of Chief Scientific Officer & Director since 2009.
He was a Scientific Advisor at Clarimedix, Inc. and a Professor at The University of Colorado.
Dr. Stowell received his undergraduate degree from The Reed Institute and his doctorate from the California Institute of Technology.
Aktiva positioner av Michael Stowell
| Företag | Position | Start |
|---|---|---|
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology Develops therapeutic targets and diagnostics | Grundare | 2009-01-01 |
Tidigare kända positioner av Michael Stowell
| Företag | Position | Slut |
|---|---|---|
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Clarimedix, Inc.
Clarimedix, Inc. Medical SpecialtiesHealth Technology Develops pipeline products for diseases associated with vascular dysfunction | Företagsledare/Principal | - |
Michael Stowells utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
AmideBio LLC
AmideBio LLC BiotechnologyHealth Technology Develops therapeutic targets and diagnostics | Health Technology |
Clarimedix, Inc.
Clarimedix, Inc. Medical SpecialtiesHealth Technology Develops pipeline products for diseases associated with vascular dysfunction | Health Technology |
The Reed Institute
The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















